Enteral Vancomycin to Eliminate MRSA Carriership of the Digestive Tract in Critically Ill Patients

Background: Carriership with methicillin resistant Staphylococcus aureus (MRSA) is a risk for the development of secondary infections in critically ill patients. Previous studies suggest that enteral vancomycin is able to eliminate enteral carriership with MRSA. Data on individual effects of this tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Buitinck, Sophie H., Koopmans, Matty, Determann, Rogier M., Jansen, Rogier R., van der Voort, Peter H. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868137/
https://www.ncbi.nlm.nih.gov/pubmed/35203865
http://dx.doi.org/10.3390/antibiotics11020263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868137/
https://www.ncbi.nlm.nih.gov/pubmed/35203865
http://dx.doi.org/10.3390/antibiotics11020263

Ejemplares similares